SEC FORM 4

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

1. Name and Address of Reporting Person^*

GENERAL ATLANTIC PARTNERS LLC

(Last)

(First)

(Middle)

C/O GENERAL ATLANTIC SERVICE CORPORATION

3 PICKWICK PLAZA

(Street)

GREENWICH

06830

(City)

(State)

(Zip)

2. Issuer Name and Ticker or Trading Symbol
CRITICAL PATH INC [ CPTH ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

Director	X	10% Owner
Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
07/09/2004

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Series D Preferred Stock	⁽³⁾	07/09/2004		J⁽³⁾			2,091,218	⁽³⁾	⁽³⁾	Common Stock	23,426,392	⁽¹²⁾	0	I	See⁽¹⁰⁾
Series D Preferred Stock	⁽¹⁾	07/09/2004		J⁽³⁾		2,091,218		⁽⁷⁾	⁽⁸⁾	Common Stock	23,426,392	⁽¹²⁾	23,426,392	I	See⁽¹⁰⁾
Series D Preferred Stock	⁽³⁾	07/09/2004		J⁽³⁾			159,091	⁽³⁾	⁽³⁾	Common Stock	1,782,180	⁽¹²⁾	0	I	See⁽¹¹⁾
Series D Preferred Stock	⁽¹⁾	07/09/2004		J⁽³⁾		159,091		⁽⁷⁾	⁽⁸⁾	Common Stock	1,782,180	⁽¹²⁾	1,782,180	I	See⁽¹¹⁾
Series E Preferred Stock	⁽²⁾	07/09/2004		J⁽⁵⁾		6,070,185		⁽⁷⁾	⁽⁹⁾	Common Stock	6,070,185	⁽⁵⁾	6,070,185	I	See⁽¹⁰⁾
Series E Preferred Stock	⁽²⁾	07/09/2004		J⁽⁶⁾		466,928		⁽⁷⁾	⁽⁹⁾	Common Stock	466,928	⁽⁶⁾	466,928	I	See⁽¹¹⁾
Common Stock Warrant (right to buy)	$4.2	07/09/2004		J⁽⁴⁾			513,468	⁽⁷⁾	11/07/2006	Common Stock	513,468	⁽¹²⁾	0	I	See⁽¹⁰⁾
Common Stock Warrant (right to buy)	$1.5	07/09/2004		J⁽⁴⁾		513,468		⁽⁷⁾	11/07/2006	Common Stock	513,468	⁽¹²⁾	513,468	I	See⁽¹⁰⁾
Common Stock Warrant (right to buy)	$4.2	07/09/2004		J⁽⁴⁾			39,062	⁽⁷⁾	11/07/2006	Common Stock	39,062	⁽¹²⁾	0	I	See⁽¹¹⁾
Common Stock Warrant (right to buy)	$1.5	07/09/2004		J⁽⁴⁾		39,062		⁽⁷⁾	11/07/2006	Common Stock	39,062	⁽¹²⁾	39,062	I	See⁽¹¹⁾

Explanation of Responses:

1. The shares of Series D Preferred Stock are convertible into the number shares of common stock of the issuer equal to the product of the number of shares of Series D Preferred Stock being converted multiplied by the quotient of (i) the Series D Accreted Value plus all dividends accrued since the previous semi-annual compounding date divided by (ii) $1.50 (subject to anti-dilution adjustments). Series D Accreted Value means, with respect to each share of Preferred Stock, the sum of $13.75 plus all dividends that have accrued and compounded semi-annually.

2. The shares of Series E Preferred Stock are convertible into the number shares of common stock of the issuer equal to the product of the number of shares of Series E Preferred Stock being converted multiplied by the quotient of (i) the Series E Accreted Value divided by (ii) $1.50 (subject to anti-dilution adjustments). Series E Accreted Value means, with respect to each share of Series E Preferred Stock, the sum of $1.50 plus all dividends that have accrued and compounded semi-annually.

3. Amendment to terms of Series D Preferred Stock originally issued on December 19, 2001.

4. Amendment to terms of Common Stock Warrant originally issued on December 19, 2001.

5. Issuance of Series E Preferred Stock upon conversion of a Convertible Subordinated Promissory Note in the aggregate amount of $9,105,278.60.

6. Issuance of Series E Preferred Stock upon conversion of a Convertible Subordinated Promissory Note in the aggregate amount of $700,392.

7. Immediately

8. There is no expiration date by which the Series D Preferred Stock must convert into common stock. If at any date after July 9, 2007 the average closing price per share of common stock for any 60 consecutive trading days is not less than 400% of the Series D Accreted Value, then the issuer has the option to redeem within 30 days all outstanding Series D Preferred Stock for cash at a price per share equal to the Series D Accreted Value plus all dividends accrued since the previous semi-annual compounding date and all dividends that would have accrued and compounded from the closing of such optional redemption until July 9, 2008. On July 9, 2008, all Series D Preferred Stock must automatically be redeemed for cash at a price per share equal to the Series D Accreted Value plus all dividends accrued since the previous semi-annual compounding date.

9. There is no expiration date by which the Series E Preferred Stock must convert into common stock. If at any date after July 9, 2007 the average closing price per share of common stock for any 60 consecutive trading days is not less than 400% of the Series E Accreted Value, then the issuer has the option to redeem within 30 days all outstanding Series E Preferred Stock for cash at a price per share equal to the Series E Accreted Value plus all dividends accrued since the previous semi-annual compounding date. On July 9, 2008, all Series E Preferred Stock must automatically be redeemed for cash at a price per share equal to the Series E Accreted Value plus all dividends accrued since the previous semi-annual compounding date.

10. By General Atlantic Partners 74, L.P., of which General Atlantic Partners, LLC ("GAP LLC") is the general partner.

11. By GapStar, LLC, of which GAP LLC is the sole member.

12. Not applicable.

Remarks:

	Matthew Nimetz, A Managing Member	07/12/2004
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.